Digipath Inc (DIGP)

[europa7]

Dr. Orser (DIGP) co-authors paper with GBLX...

Cannabis Chemovar Nomenclature Misrepresents Chemical and Genetic Diversity; Survey of Variationsin Chemical Profiles and Genetic Markers in Nevada Medical Cannabis Samples
Ulrich Reimann-Philipp,1 Mark Speck,2 Cindy Orser,3 Steve Johnson,3 Aaron Hilyard,3 Helen Turner,2 Alexander J. Stokes,4 and Andrea L. Small-Howard1,*
https://www.liebertpub.com/doi/pdf/10.1089/CAN.2018.0063

GB Sciences Study Shows Nevada’s Cannabis Strain Names Have No Correlation to Active Ingredients
https://gbsciences.com/2019/03/29/nevada-chemical-diversity/

GB Sciences is proud to applaud the contributors to this research and paper: GB Sciences’ own Chief Science Officer, Dr. Andrea Small-Howard, and Lead Botanist, Dr. Ulrich Reimann-Philipp, join co-authors including Dr. Helen Turner, VP of Innovation and Dean of the Division of Natural Sciences and Mathematics at Chaminade University, Dr. Mark Speck, Senior Bioinformaticist at Chaminade University, Dr. Alexander Stokes, President of Makai Biotechnology, LLC, and Dr. Cindy Orser, Chief Science Officer at Digipath Labs, Inc. in publishing:

“Cannabis chemovar nomenclature misrepresents chemical and genetic diversity; survey of variations in chemical profiles and genetic markers in Nevada medical cannabis samples.” The link to the article is found at https://www.liebertpub.com/doi/pdf/10.1089/CAN.2018.0063.